These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30562356)

  • 1. HIV-1 subtype diversity, transmission networks and transmitted drug resistance amongst acute and early infected MSM populations from Coastal Kenya.
    Hassan AS; Esbjörnsson J; Wahome E; Thiong'o A; Makau GN; Price MA; Sanders EJ
    PLoS One; 2018; 13(12):e0206177. PubMed ID: 30562356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
    Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C
    PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of RT-related transmitted drug resistance in non-CRF01_AE among HIV type 1-infected men who have sex with men in the 7 cities of China.
    Zhao B; Han X; Xu J; Hu Q; Chu Z; Zhang J; Lu L; Wang Z; Fu J; Chen X; Yan H; Zhuang M; Wang L; Sun A; Zhang CM; Shang H
    J Acquir Immune Defic Syndr; 2015 Mar; 68(3):250-5. PubMed ID: 25469530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 subtype diversity, drug resistance, and genetic transmission networks in men who have sex with men with virologic failure in antiretroviral therapy in Sichuan, China, 2011 to 2017.
    Yuan D; Du Z; Zhou J; Ye L; Su L; Yang H; Yuan F; Li Y; Liu H; Zhai W; Liang S; Yang S
    Medicine (Baltimore); 2019 Oct; 98(43):e17585. PubMed ID: 31651864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and Transmitted HIV-1 Drug Resistance among Treatment-Naïve Individuals in Israel, 2010-2018.
    Wagner T; Zuckerman NS; Halperin T; Chemtob D; Levy I; Elbirt D; Shachar E; Olshtain-Pops K; Elinav H; Chowers M; Itsomin V; Riesenberg K; Wax M; Shirazi R; Gozlan Y; Matus N; Girshengorn S; Marom R; Mendelson E; Turner D; Mor O
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic.
    Pineda-Peña AC; Schrooten Y; Vinken L; Ferreira F; Li G; Trovão NS; Khouri R; Derdelinckx I; De Munter P; Kücherer C; Kostrikis LG; Nielsen C; Littsola K; Wensing A; Stanojevic M; Paredes R; Balotta C; Albert J; Boucher C; Gomez-Lopez A; Van Wijngaerden E; Van Ranst M; Vercauteren J; Vandamme AM; Van Laethem K
    PLoS One; 2014; 9(7):e101738. PubMed ID: 25003369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update.
    Lunar MM; Židovec Lepej S; Tomažič J; Vovko TD; Pečavar B; Turel G; Maver M; Poljak M
    PLoS One; 2018; 13(4):e0196670. PubMed ID: 29698470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 transmission networks across Cyprus (2010-2012).
    Kostrikis LG; Hezka J; Stylianou DC; Kostaki E; Andreou M; Kousiappa I; Paraskevis D; Demetriades I
    PLoS One; 2018; 13(4):e0195660. PubMed ID: 29684083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short communication: HIV type 1 transmitted drug resistance and evidence of transmission clusters among recently infected antiretroviral-naive individuals from Ugandan fishing communities of Lake Victoria.
    Nazziwa J; Njai HF; Ndembi N; Birungi J; Lyagoba F; Gershim A; Nakiyingi-Miiro J; Nielsen L; Mpendo J; Nanvubya A; Debont J; Grosskurth H; Kamali A; Seeley J; Kaleebu P;
    AIDS Res Hum Retroviruses; 2013 May; 29(5):788-95. PubMed ID: 23173702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in HIV-1-transmitted drug resistance among ART-naïve youths at the China-Myanmar border during 2009 ~ 2017.
    Ding Y; Chen M; Wang J; Yang Y; Feng Y; Wang L; Duan S; Lin Q; Xing H; Ma Y; Han M; Ma L
    BMC Infect Dis; 2021 Jan; 21(1):93. PubMed ID: 33478415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing proportions of HIV-1 non-B subtypes and of NNRTI resistance between 2013 and 2016 in Germany: Results from the national molecular surveillance of new HIV-diagnoses.
    Hauser A; Hofmann A; Meixenberger K; Altmann B; Hanke K; Bremer V; Bartmeyer B; Bannert N
    PLoS One; 2018; 13(11):e0206234. PubMed ID: 30408827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Transmission Patterns Within and Between Risk Groups in Coastal Kenya.
    Nduva GM; Hassan AS; Nazziwa J; Graham SM; Esbjörnsson J; Sanders EJ
    Sci Rep; 2020 Apr; 10(1):6775. PubMed ID: 32317722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transmitted drug resistance among HIV infected men who have sex with men in Tianjin, 2014-2017].
    Zheng MN; Ning TL; Zhou N; Zhao X; Li L; Zhu JJ; Cheng SH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 May; 39(5):619-624. PubMed ID: 29860805
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study.
    Drescher SM; von Wyl V; Yang WL; Böni J; Yerly S; Shah C; Aubert V; Klimkait T; Taffé P; Furrer H; Battegay M; Ambrosioni J; Cavassini M; Bernasconi E; Vernazza PL; Ledergerber B; Günthard HF; Kouyos RD;
    Clin Infect Dis; 2014 Jan; 58(2):285-94. PubMed ID: 24145874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 transmitted drug resistance-associated mutations and mutation co-variation in HIV-1 treatment-naïve MSM from 2011 to 2013 in Beijing, China.
    Jiao Y; Li S; Li Z; Zhang Z; Zhao J; Li L; Wang L; Yin Q; Wang Y; Zeng Z; Shao Y; Ma L
    BMC Infect Dis; 2014 Dec; 14():689. PubMed ID: 25510523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phylogenetic investigation of transmission pathways of drug-resistant HIV-1 utilizing pol sequences derived from resistance genotyping.
    Kaye M; Chibo D; Birch C
    J Acquir Immune Defic Syndr; 2008 Sep; 49(1):9-16. PubMed ID: 18667928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Immunodeficiency Virus (HIV) Drug Resistance, Phylogenetic Analysis, and Superinfection Among Men Who Have Sex with Men and Transgender Women in Sub-Saharan Africa: HIV Prevention Trials Network (HPTN) 075 Study.
    Sivay MV; Palumbo PJ; Zhang Y; Cummings V; Guo X; Hamilton EL; McKinstry L; Ogendo A; Kayange N; Panchia R; Dominguez K; Chen YQ; Sandfort TGM; Eshleman SH
    Clin Infect Dis; 2021 Jul; 73(1):60-67. PubMed ID: 32761071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 diversity, transmission dynamics and primary drug resistance in Angola.
    Bártolo I; Zakovic S; Martin F; Palladino C; Carvalho P; Camacho R; Thamm S; Clemente S; Taveira N
    PLoS One; 2014; 9(12):e113626. PubMed ID: 25479241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 transmitted drug resistance in Brighton, UK, from 2014 to 2020.
    Richardson D; Fitzpatrick C; Parkes L; Roberts J; Mulka L
    Int J STD AIDS; 2021 Feb; 32(2):199-201. PubMed ID: 33327896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 infection in high risk men who have sex with men in Mombasa, Kenya.
    Sanders EJ; Graham SM; Okuku HS; van der Elst EM; Muhaari A; Davies A; Peshu N; Price M; McClelland RS; Smith AD
    AIDS; 2007 Nov; 21(18):2513-20. PubMed ID: 18025888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.